Citius Pharmaceuticals, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent
Citius Pharmaceuticals, Inc. (CTXR) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent of -4.60% for the 12-month period ending 2015-09-30, per its 10-K filed 2015-12-14.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense · last filed 2015-12-14
- Citius Pharmaceuticals, Inc. effective income tax rate reconciliation, nondeductible expense, percent for fiscal 2015 was -4.60%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 9 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent 12 month |
|---|---|---|
| 2015-09-30 | -4.60% 10-K · filed 2015-12-14 | |
| 2014-09-30 | 0.00% 10-K · filed 2015-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |